All Stories

  1. Accessibility of Ontario pharmacies offering COVID-19 vaccination by rurality, community material deprivation, and ethnic concentration : A repeated cross-sectional geospatial analysis
  2. Association Between Opioid-Related Mortality and History of Surgical Procedure: A Population-Based Case-Control Study
  3. Health utilities in adults with hemophilia A: A retrospective cohort study
  4. Association between Pharmacists’ Country of Qualifying Education and Practising in a Hospital Setting: A Cross-Sectional Ontario Study
  5. Post‐initiation predictors of discontinuation of the sodium‐glucose cotransporter‐2 inhibitors: A comparative cohort study from the United Kingdom
  6. Herpes zoster and human papillomavirus vaccination opportunities identified using electronic prompts at the time of scheduling influenza or COVID-19 vaccines
  7. Évolution et déterminants de la vaccination contre la grippe saisonnière après une maladie cardiovasculaire au Canada : étude transversale pancanadienne répétée
  8. Cost Effectiveness of Implementing a Universal Birth Hepatitis B Vaccination Program in Ontario
  9. Stepping up to the Canadian opioid crisis: a longitudinal analysis of the correlation between socioeconomic status and population rates of opioid-related mortality, hospitalization and emergency department visits (2000–2017)
  10. Five comparative cohorts to assess the risk of genital tract infections associated with sodium‐glucose cotransporter‐2 inhibitors initiation in type 2 diabetes mellitus
  11. The association between the rate of potentially pharmacist-manageable emergency department visits and community income level and primary care provider availability: A spatial analysis
  12. Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs
  13. National trends in population rates of opioid‐related mortality, hospitalization and emergency department visits in Canada between 2000 and 2017. A population‐based study
  14. Sodium-glucose cotransporter-2 inhibitors and urinary tract infections: A propensity score matched population-based cohort study.
  15. Trends and Determinants of Self-Reported Aspirin Use among Patients with Diabetes Stratified by the Presence and Risk of Cardiovascular Diseases - Repeated Pan-Canadian Cross-Sectional Study
  16. National trends in population rates of opioid‐related mortality, hospitalization and emergency department visits in Canada between 2000 and 2017. A population‐based study
  17. Economic evaluation of pharmacists prescribing for minor ailments in Ontario, Canada: a cost-minimization analysis
  18. The Impact of Prescription Medication Cost Coverage on Oral Medication Use for Hypertension and Type 2 Diabetes Mellitus
  19. Development of comparable algorithms to measure primary care indicators using administrative health data across three Canadian provinces
  20. Comparative risk of cardiac arrhythmias associated with acetylcholinesterase inhibitors used in treatment of dementias – A narrative review
  21. Estimates of population‐based incidence of malignant arrhythmias associated with medication use—a narrative review
  22. The availability of pharmacists with Additional Prescribing Authorization in relation to the distribution of vulnerable populations - A cross-sectional study
  23. Achieving cross provincial comparisons of osteoporosis screening performance from administrative health data.
  24. Cost-Effectiveness of Tenofovir Alafenamide for Treatment of Chronic Hepatitis B in Canada
  25. The proportion, conditions, and predictors of emergency department visits that can be potentially managed by pharmacists with expanded scope of practice
  26. 128 - Trend and Determinants of Cholesterol-Lowering Medication Use Among Patients With Diabetes Mellitus in Canada: A Repeated Cross-Sectional Study
  27. Pharmacy patron perspectives of community pharmacist administered influenza vaccinations
  28. Capsule Commentary on Goto et al.’s Incidence of Acute Cardiovascular Event After Acute Exacerbation of COPD
  29. Pharmacists as immunizers, their pharmacies and immunization services: A survey of Ontario community pharmacists
  30. Trends in Blood Glucose Test Strip Utilization: A Population-Wide Analysis in Saskatchewan, Canada
  31. Self-efficacy for deprescribing: A survey for health care professionals using evidence-based deprescribing guidelines
  32. Does the association between adherence to statin medications and mortality depend on measurement approach? A retrospective cohort study
  33. Managing medications during Ramadan fasting
  34. Protecting our patients by protecting ourselves
  35. Multiple-domain Versus Single-domain Measurements of Socioeconomic Status (SES) for Predicting Nonadherence to Statin Medications
  36. Abstract 19486: Does the Association Between Adherence to Statin Medications and Mortality Depend on the Measurement Approach? A Retrospective Cohort Study
  37. Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis
  38. Trends in Prevalence, Incidence and Pharmacologic Management of Diabetes Mellitus Among Seniors Newly Admitted to Long-Term Care Facilities in Saskatchewan between 2003 and 2011
  39. Socioeconomic Status and Nonadherence to Antihypertensive Drugs: A Systematic Review and Meta-Analysis
  40. Proportion and risk indicators of nonadherence to antihypertensive therapy: a meta-analysis
  41. Use and Misuse of Ezetimibe: Analysis of Use and Cost in Saskatchewan, a Canadian Jurisdiction With Broad Access
  42. Neighbourhood Income and Cardiac Rehabilitation Access as Determinants of Nonattendance and Noncompletion
  43. Pharmacologic Management of Diabetes among Seniors Newly Admitted to Long-term Care Facilities in Saskatchewan
  44. Incidence and Prevalence of Diabetes in Residents of Saskatchewan Long-Term Care Facilities between 2003 and 2011
  45. Pharmacist Intervention in Cardiac Rehabilitation